Erica Rogers - Jan 11, 2023 Form 4 Insider Report for Silk Road Medical Inc (SILK)

Role
President and CEO, Director
Signature
/s/Mhairi Jones, by power of attorney
Stock symbol
SILK
Transactions as of
Jan 11, 2023
Transactions value $
-$299,580
Form type
4
Date filed
1/13/2023, 04:32 PM
Previous filing
Dec 14, 2022
Next filing
Feb 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILK Common Stock Options Exercise $9.6K +6K +2.44% $1.60* 252K Jan 11, 2023 Direct F1
transaction SILK Common Stock Sale -$309K -6K -2.38% $51.53 246K Jan 11, 2023 Direct F1
holding SILK Common Stock 83.8K Jan 11, 2023 Trustees of The Surace/Rogers Family Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SILK Option (right to buy) Options Exercise $0 -6K -14.07% $0.00 36.7K Jan 11, 2023 Common Stock 6K $1.60 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on August 8, 2022.
F2 These shares are held directly by Kevin J. Surace and Erica J. Rogers, as Trustees of The Surace Rogers Family Trust.
F3 All of the shares subject to this option are fully vested and exercisable as of the date hereof.